M22-128: EPICORE DLBCL-4
This study is evaluating a combination of epcoritamab and lenalidomide for older adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), aiming to improve treatment outcomes and response rates.
S1918: New Approaches for Lymphoma in Older Adults with Aggressive Variants
This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone [R-miniCHOP]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma.